133 / 1084
OE-5 Study
Median survival (95% CI)
CF
2.02
(1.80, 2.38) ys
ECX
2.15
(1.93, 2.53) ys
HR
0.92
0.50
0.75
1.00
P ro p o r t io n s u rv iv in g
CF
ECX
© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick
Alderson D et al.
ASCO
2015; #4002
(0.79, 1.08)
P-
value
0.8582
3-year survival (95% CI)
CF
39% (35%, 44%)
ECX
42% (37%, 46%)
0.00
0.25
446 343 229 172 124 91 70 45 23
ECX
451 345 227 167 121 71 46 21 13
CF
At risk
0
1
2
3
4
5
6
7
8
Time from randomisation (Years)